SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Clinical: Gabapentin Enacarbil Phase 4 Trial - Nighttime Agitation

clinical 666 words KG: AD 2026-03-29

kind:clinical-trial section:clinical-trials state:published

Contents

Gabapentin Enacarbil Phase 4 Trial - Nighttime Agitation

Knowledge Graph

Related Hypotheses (30)

Trinucleotide Repeat Sequestration via CRISPR-Guided RNA Tar
Score: 0.48 Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuro
Score: 0.42 Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59 SASP-Driven Aquaporin-4 Dysregulation
Score: 0.59 PARP1 Inhibition Therapy
Score: 0.58

Competitive APOE4 Domain Stabilization Peptides
Score: 0.56 APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54 Glymphatic System-Enhanced Antibody Clearance Reversal
Score: 0.54 Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53 Phase-Separated Organelle Targeting
Score: 0.52 Heat Shock Protein 70 Disaggregase Amplification
Score: 0.51 Aquaporin-4 Polarization Rescue
Score: 0.51 Stress Granule Phase Separation Modulators
Score: 0.49 Microglial Purinergic Reprogramming
Score: 0.48 Tau-Independent Microtubule Stabilization via MAP6 Enhanceme
Score: 0.48 Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.48 Complement C1q Mimetic Decoy Therapy
Score: 0.48 RNA Granule Nucleation Site Modulation
Score: 0.48 APOE Isoform Expression Across Glial Subtypes
Score: 0.48 Arginine Methylation Enhancement Therapy
Score: 0.46 Cryptic Exon Silencing Restoration
Score: 0.46 Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46 Cross-Seeding Prevention Strategy
Score: 0.45 Reelin-Mediated Cytoskeletal Stabilization Protocol
Score: 0.45 HCN1-Mediated Resonance Frequency Stabilization Therapy
Score: 0.44 Mitochondrial Transfer Pathway Enhancement
Score: 0.44 Sphingolipid Metabolism Reprogramming
Score: 0.44 Complement C1q Subtype Switching
Score: 0.44 Mitochondrial-Lysosomal Contact Site Engineering
Score: 0.43 Lysosomal Positioning Dynamics Modulation
Score: 0.43

Related Analyses (9)

Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived 4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived

Synaptic pruning by microglia in early AD
neurodegeneration · archived CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · archived TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed

Related Experiments (3)

AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40 AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40 Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.40

See Also (14)

Tau Consortium
organization · KG edge: associated_with Proteome Atlas for Neurodegenerative Diseases
mechanism · KG edge: regulates Age-Sensitive Cortical Vulnerability in Parkinson's Dis
mechanism · KG edge: associated_with Packard Center for ALS Research
institution · KG edge: implicated_in Dementia Australia
institution · KG edge: causes

AMBRA1 Gene
gene · KG edge: implicated_in AGER Gene
gene · KG edge: implicated_in ACTB Gene
gene · KG edge: implicated_in ABCG1 Gene
gene · KG edge: implicated_in ABCD3 Gene
gene · KG edge: implicated_in ABCB1 (MDR1) - ATP Binding Cassette Subfamily B Member
gene · KG edge: implicated_in ABCA1 - ATP-Binding Cassette Transporter A1
gene · KG edge: implicated_in A2M Gene
gene · KG edge: implicated_in Neurodegeneration
disease · KG edge: causes

Knowledge Graph (12 edges)

AD causes neurodegeneration

AD inhibits cholinergic_transmission

AD causes memory_loss

AD associated_with TAU

AD regulates PROTEOME

AD associated_with GLYCOLYTIC_PATHWAY

AD causes IMMUNE_TOL

AD causes DEMENTIA

AD associated_with CHOLINERGIC_TRANSMISSION

TAU associated_with AD

SciDEX — scidex.ai — Dashboard | Atlas